COOPER COMPANIES, INC.
COOAPI behind this page
COO Q1 2026 request
Playground key active
/api/financials?ticker=COO&year=2026&quarter=1
Pick an endpoint and run the request.
Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Revenue | 1,024.1 | 964.7 | +6.2% |
Show Product Lines breakouts |
|||
| Fertility · Coopersurgical Segment | 126.6 | 119.7 | +5.8% |
| Office and surgical · Coopersurgical Segment | 202.4 | 198.9 | +1.8% |
| Sphere, other · Coopervision Segment | 343.9 | 326.7 | +5.3% |
| Toric and multifocal · Coopervision Segment | 351.2 | 319.4 | +10.0% |
Show Business Segments breakouts |
|||
| CooperSurgical Segment · Operating Segments | 329 | 318.6 | +3.3% |
| Coopersurgical Segment · Operating Segments | 329 | 318.6 | +3.3% |
| CooperVision Segment · Operating Segments | 695.1 | 646.1 | +7.6% |
| Coopervision Segment · Operating Segments | 695.1 | 646.1 | +7.6% |
Show Geography breakouts |
|||
| Europe | 326.4 | 287.5 | +13.5% |
| Rest of world | 183.8 | 180.8 | +1.7% |
| US | 513.9 | 496.4 | +3.5% |
| Cost of Revenue | 328.9 | 304.5 | +8.0% |
Show Business Segments breakouts |
|||
| CooperSurgical Segment · Operating Segments | 108.1 | 99.5 | +8.6% |
| CooperVision Segment · Operating Segments | 220.8 | 205 | +7.7% |
| Gross Profit | 695.2 | 660.2 | +5.3% |
| Selling, General & Administrative | 390.2 | 387.9 | +0.6% |
Show Business Segments breakouts |
|||
| CooperSurgical Segment · Operating Segments | 128.4 | 135.9 | -5.5% |
| CooperVision Segment · Operating Segments | 237.6 | 229.9 | +3.3% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 24.2 | 22.1 | +9.5% |
| Research & Development | 44.3 | 40.7 | +8.8% |
Show Business Segments breakouts |
|||
| CooperSurgical Segment · Operating Segments | 21.9 | 18.2 | +20.3% |
| CooperVision Segment · Operating Segments | 22.4 | 22.5 | -0.4% |
| Amortization Of Intangible Assets | 47.9 | 49.6 | -3.4% |
Show Business Segments breakouts |
|||
| CooperSurgical Segment · Operating Segments | 43.8 | 44.8 | -2.2% |
| CooperVision Segment · Operating Segments | 4.1 | 4.8 | -14.6% |
| Operating Income | 212.8 | 182 | +16.9% |
Show Business Segments breakouts |
|||
| CooperSurgical Segment · Operating Segments | 26.8 | 20.2 | +32.7% |
| CooperVision Segment · Operating Segments | 210.2 | 183.9 | +14.3% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -24.2 | -22.1 | -9.5% |
| Interest Expense | 22.4 | 26 | -13.8% |
| Other Non-Operating Income (Expense) | -1.8 | 2.7 | -166.7% |
| Income Before Taxes | 192.2 | 153.3 | +25.4% |
| Income Tax Expense (Benefit) | 61.4 | 49 | +25.3% |
| Net Income | 130.8 | 104.3 | +25.4% |
Show Equity Components breakouts |
|||
| Retained Earnings | 130.8 | 104.3 | +25.4% |
| EPS (Basic) | 0.67 | 0.52 | +28.8% |
| EPS (Diluted) | 0.66 | 0.52 | +26.9% |
| Wtd Avg Shares (Basic) | 195.8 | 199.7 | -2.0% |
| Wtd Avg Shares (Diluted) | 196.7 | 201.2 | -2.2% |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax | -4 | -2 | -100.0% |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | 76.5 | -66.7 | +214.7% |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | 203.3 | 35.6 | +471.1% |
| Non-Operating Income (Expense) | -1.8 | 2.7 | -166.7% |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax | 0.7 | 6.9 | -89.9% |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 124.9 | 100.9 | +23.8% |
| Accounts Receivable | 807.1 | 716.4 | +12.7% |
| Inventory | 876.4 | 842.9 | +4.0% |
| Prepaid Expenses & Other Current Assets | 325.4 | 326.8 | -0.4% |
| Total Current Assets | 2,133.8 | 1,987 | +7.4% |
| Non-Current Assets | |||
| Goodwill | 3,905.4 | — | — |
| Deferred Tax Assets | 2,038.3 | 2,175.3 | -6.3% |
| Other Non-Current Assets | 688.4 | 663.7 | +3.7% |
| Total Assets | 12,424.2 | — | — |
Show Business Segments breakouts |
|||
| CooperSurgical Segment · Operating Segments | 4,584.6 | — | — |
| CooperVision Segment · Operating Segments | 7,655.7 | — | — |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 183.9 | — | — |
| Intangible Assets | 1,540.5 | — | — |
| Other Assets | |||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 2,116.7 | 1,864.7 | +13.5% |
| Intangible Assets Net Excluding Goodwill | 1,541.6 | — | — |
| Current Liabilities | |||
| Debt Current | 620.7 | 48.7 | +1174.5% |
| Accounts Payable | 225.8 | 201.5 | +12.1% |
| Employee Related Liabilities Current | 209.6 | 190.4 | +10.1% |
| Deferred Revenue (Current) | 129.9 | 126.3 | +2.9% |
| Other Liabilities Current | 409.7 | 432.7 | -5.3% |
| Total Current Liabilities | 1,595.7 | 999.6 | +59.6% |
| Non-Current Liabilities | |||
| Deferred Tax Liabilities | 96.3 | 95.2 | +1.2% |
| Accrued Income Taxes Noncurrent | 5.6 | 54.3 | -89.7% |
| Contract With Customer Liability Noncurrent | 206.4 | 193.4 | +6.7% |
| Other Non-Current Liabilities | 277.2 | 261 | +6.2% |
| Total Liabilities | 4,060.2 | 4,094.7 | -0.8% |
| Long-Term Debt | 1,877.3 | 2,489.1 | -24.6% |
| Other Liabilities | |||
| Long Term Debt And Capital Lease Obligations | 1,879 | 2,491.2 | -24.6% |
| Stockholders' Equity | |||
| Common Stock | 21.8 | 21.7 | +0.5% |
| Additional Paid-In Capital | 1,987.1 | 1,928.3 | +3.0% |
| Accumulated Other Comprehensive Income | -334 | -490.4 | +31.9% |
| Retained Earnings | 7,774.1 | 7,372.7 | +5.4% |
| Treasury Stock Common Value | -1,085.2 | -705 | -53.9% |
| Total Stockholders' Equity | 8,363.8 | 8,127.3 | +2.9% |
| Minority Interest | 0.2 | 0.2 | 0.0% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 8,364 | 8,127.5 | +2.9% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | 1.7 | -4.9 | +134.7% |
| Accumulated Gain (Loss), Net, Cash Flow Hedge, Before Tax, Parent | 18.4 | 57.2 | -67.8% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent | 14 | 42.9 | -67.4% |
| Accumulated Other Comprehensive Income | -334 | -490.4 | +31.9% |
| Accumulated Translation Adjustment | -349.7 | -528.4 | +33.8% |
| Additional Paid In Capital | 1,987.1 | 1,928.3 | +3.0% |
| Common Shares | 20 | 19.9 | +0.5% |
| Noncontrolling Interest | 0.2 | 0.2 | 0.0% |
| Retained Earnings | 7,774.1 | 7,372.7 | +5.4% |
| Treasury Stock | 1.8 | 1.8 | 0.0% |
| Treasury Stock Common | -1,085.2 | -705 | -53.9% |
| Total Liabilities & Equity | 12,424.2 | 12,222.2 | +1.7% |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 95.5 | 91 | +4.9% |
| Business Combination Contingent Consideration Arrangements Settlement Amount Of Contingent Consideration Liability | -0.5 | — | — |
| Increase Decrease In Operating Capital | -36.1 | -75.6 | +52.2% |
| Deferred Income Taxes | 43.6 | 34.6 | +26.0% |
| Other Non-Cash Items | 27.6 | 36.3 | -24.0% |
| Net Cash from Operations | 260.9 | 190.6 | +36.9% |
| Investing Activities | |||
| Capital Expenditures | -102.2 | -89.4 | -14.3% |
| Payments To Acquire Businesses And Assets Net Of Cash Acquired And Other | -0.7 | -7.4 | +90.5% |
| Net Cash from Investing | -102.9 | -96.8 | -6.3% |
| Financing Activities | |||
| Proceeds From Issuance Of Long Term Debt | 875.4 | 670.3 | +30.6% |
| Repayments Of Long Term Debt | -904.2 | -729.5 | -23.9% |
| Payments To Acquire Business Gross Installments | -44.5 | -47.1 | +5.5% |
| Proceeds From Repayments Of Short Term Debt | 22 | 16 | +37.5% |
| Proceeds From Payments Of Share Based Arrangement | -6.7 | -8.5 | +21.2% |
| Share Repurchases | -92.5 | — | — |
| Proceeds From Stock Plans | 3.9 | 2.2 | +77.3% |
| Payment For Contingent Consideration Liability Financing Activities | -1.3 | — | — |
| Net Cash from Financing | -147.9 | -96.6 | -53.1% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 4.3 | -3.9 | +210.3% |
| Net Change in Cash | 14.4 | -6.7 | +314.9% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 125 | 101 | +23.8% |
| Restricted Cash And Cash Equivalents At Carrying Value | 0.1 | 0.1 | 0.0% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.